10/2/23

RRP Fast-Track to a Cure Event

A discussion on how RRP implements an entrepreneurial approach to deliver a cancer prevention therapy for a rare genetic disease called RUNX1-FPD with RRP's Director of Development Alex Gonzalez, RRP Executive Director Dr. Katrin Ericson, and RRP co-founder Tim Babich.

Previous

2024 X-Out Cancer Campaign

Next

Interface guided phenotyping of coding variants in the transcription factor RUNX1 with SEUSS